Status:
RECRUITING
Evaluation of the Reliability of AAR as an Independent Tool for Surgical Indication in Nasal Obstruction
Lead Sponsor:
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Conditions:
Nasal Obstruction
Eligibility:
All Genders
18+ years
Brief Summary
Nasal obstruction (NO) affects \~30% of the population and is a very common reason for consultation in otorhinolaryngology (ORL). In the majority of cases, the origin is inflammatory (allergic rhiniti...
Eligibility Criteria
Inclusion Criteria:
- Patients aged 18 years or older with nasal obstruction (NO).
- Patients scheduled for surgery: septoplasty ± turbinoplasty ± rhinoplasty for nasal obstruction.
- Patients who have undergone a preoperative rhinomanometry assessment.
- Patients consented to participation
Exclusion Criteria:
- Nasal polyps.
- Chronic edematous-purulent rhinosinusitis (e.g., cystic fibrosis).
- Crusting rhinosinusitis (e.g., sarcoidosis, granulomatosis with polyangiitis [Wegener's]).
- Current or previously treated nasal or sinus tumors, or patients undergoing tumor work-up
Key Trial Info
Start Date :
January 27 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07379775
Start Date
January 27 2026
End Date
March 1 2028
Last Update
April 14 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de la Dracénie
Draguignan, Var, France, 83007